DERM Dermira, Inc.

NASDAQ
$6.14

Dermira, Inc. (DERM) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -16.5% since its last earnings release on August 12, 2026.

Dermira Reported In-line with Estimates
Wednesday, August 12, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs $0.01
Rev est $22.74M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.15

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dermira, Inc.

Dermira Inc is a biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.